AU2006270380A1 - Highly selective serotonin and norepinephrine dual reuptake inhibitor and use thereof - Google Patents
Highly selective serotonin and norepinephrine dual reuptake inhibitor and use thereof Download PDFInfo
- Publication number
- AU2006270380A1 AU2006270380A1 AU2006270380A AU2006270380A AU2006270380A1 AU 2006270380 A1 AU2006270380 A1 AU 2006270380A1 AU 2006270380 A AU2006270380 A AU 2006270380A AU 2006270380 A AU2006270380 A AU 2006270380A AU 2006270380 A1 AU2006270380 A1 AU 2006270380A1
- Authority
- AU
- Australia
- Prior art keywords
- compound
- disorder
- phenol
- alkyl
- ethyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/46—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C215/64—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/06—Anti-spasmodics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/52—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups or amino groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Psychiatry (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Nutrition Science (AREA)
- Addiction (AREA)
- Gynecology & Obstetrics (AREA)
- Hospice & Palliative Care (AREA)
- Cardiology (AREA)
- Psychology (AREA)
- Anesthesiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Emergency Medicine (AREA)
- Urology & Nephrology (AREA)
- Child & Adolescent Psychology (AREA)
- Reproductive Health (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US69966505P | 2005-07-15 | 2005-07-15 | |
US60/699,665 | 2005-07-15 | ||
PCT/US2006/026991 WO2007011594A2 (fr) | 2005-07-15 | 2006-07-13 | Inhibiteur double hautement selectif de recaptage de la serotonine et de la noradrenaline et son utilisation |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2006270380A1 true AU2006270380A1 (en) | 2007-01-25 |
Family
ID=37453209
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2006270380A Abandoned AU2006270380A1 (en) | 2005-07-15 | 2006-07-13 | Highly selective serotonin and norepinephrine dual reuptake inhibitor and use thereof |
Country Status (20)
Country | Link |
---|---|
US (1) | US20070015828A1 (fr) |
EP (1) | EP1904434A2 (fr) |
JP (1) | JP2009501229A (fr) |
KR (1) | KR20080034921A (fr) |
CN (1) | CN101223129A (fr) |
AR (1) | AR057662A1 (fr) |
AU (1) | AU2006270380A1 (fr) |
BR (1) | BRPI0613031A2 (fr) |
CA (1) | CA2615362A1 (fr) |
CR (1) | CR9661A (fr) |
EC (1) | ECSP088104A (fr) |
GT (1) | GT200600308A (fr) |
IL (1) | IL188614A0 (fr) |
MX (1) | MX2008000680A (fr) |
NO (1) | NO20080006L (fr) |
PE (1) | PE20070247A1 (fr) |
RU (1) | RU2007149183A (fr) |
TW (1) | TW200740724A (fr) |
WO (1) | WO2007011594A2 (fr) |
ZA (1) | ZA200800408B (fr) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060134210A1 (en) * | 2004-12-22 | 2006-06-22 | Astrazeneca Ab | Solid dosage form comprising proton pump inhibitor and suspension made thereof |
WO2007067501A1 (fr) * | 2005-12-05 | 2007-06-14 | Wyeth | Procede pour la synthese selective d'enantiomeres de 1-(2-amino-1-phenyl-ethyl)-cyclohexanols substitues |
MX2007016179A (es) | 2006-04-17 | 2008-03-11 | Teva Pharma | Formas cristalinas de o-desmetilvenlafaxina. |
TW200806282A (en) * | 2006-05-05 | 2008-02-01 | Wyeth Corp | Solid dosage formulations |
KR101019453B1 (ko) * | 2006-07-26 | 2011-03-07 | 테바 파마슈티컬 인더스트리즈 리미티드 | O-데스메틸벤라팍신의 합성 방법 |
US20090035370A1 (en) * | 2007-08-02 | 2009-02-05 | Drugtech Corporation | Dosage form and method of use |
CA2706775A1 (fr) | 2007-11-26 | 2009-06-04 | Teva Pharmaceutical Industries Ltd. | Formes cristallines de fumarate de o-desmethylvenlafaxine |
US9339500B2 (en) * | 2008-03-04 | 2016-05-17 | Intra-Cellular Therapies, Inc. | Methods of treating vasomotor symptoms |
US20100016638A1 (en) * | 2008-07-21 | 2010-01-21 | Zdenko Hamersak | Method for preparation of o-desmethylvenlafaxine using polythiolates |
JP2013510176A (ja) * | 2009-11-06 | 2013-03-21 | ピエール ファーブル メディカモン | (1s,2r)−2−(アミノメチル)−n,n−ジエチル−1−フェニルシクロプロパンカルボキサミドの新規結晶形態 |
CA2795023A1 (fr) | 2010-03-29 | 2011-10-06 | Pliva Hrvatska D.O.O. | Formes cristallines du fumarate de o-desmethylvenlafaxine |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4535186A (en) * | 1983-04-19 | 1985-08-13 | American Home Products Corporation | 2-Phenyl-2-(1-hydroxycycloalkyl or 1-hydroxycycloalk-2-enyl)ethylamine derivatives |
US6274171B1 (en) * | 1996-03-25 | 2001-08-14 | American Home Products Corporation | Extended release formulation of venlafaxine hydrochloride |
DK1360169T3 (da) * | 2001-02-12 | 2007-11-26 | Wyeth Corp | Succinatsalt af O-desmethyl-venlafaxin |
RU2006127437A (ru) * | 2004-02-06 | 2008-03-20 | Вайет (Us) | Соли о-десметилвенлафаксина в виде дисперсных частиц и их применение |
JP2008534592A (ja) * | 2005-03-31 | 2008-08-28 | ワイス | O−デスメチルベンラファキシンおよびバゼドキシフェンの組み合わせ生成物およびその使用 |
-
2006
- 2006-07-13 JP JP2008521551A patent/JP2009501229A/ja not_active Withdrawn
- 2006-07-13 CN CNA2006800258619A patent/CN101223129A/zh active Pending
- 2006-07-13 AR ARP060103013A patent/AR057662A1/es unknown
- 2006-07-13 PE PE2006000834A patent/PE20070247A1/es not_active Application Discontinuation
- 2006-07-13 EP EP06786969A patent/EP1904434A2/fr not_active Withdrawn
- 2006-07-13 MX MX2008000680A patent/MX2008000680A/es unknown
- 2006-07-13 KR KR1020087003405A patent/KR20080034921A/ko not_active Application Discontinuation
- 2006-07-13 US US11/485,663 patent/US20070015828A1/en not_active Abandoned
- 2006-07-13 RU RU2007149183/04A patent/RU2007149183A/ru not_active Application Discontinuation
- 2006-07-13 TW TW095125667A patent/TW200740724A/zh unknown
- 2006-07-13 AU AU2006270380A patent/AU2006270380A1/en not_active Abandoned
- 2006-07-13 WO PCT/US2006/026991 patent/WO2007011594A2/fr active Application Filing
- 2006-07-13 CA CA002615362A patent/CA2615362A1/fr not_active Abandoned
- 2006-07-13 BR BRPI0613031-3A patent/BRPI0613031A2/pt not_active IP Right Cessation
- 2006-07-19 GT GT200600308A patent/GT200600308A/es unknown
-
2007
- 2007-01-15 CR CR9661A patent/CR9661A/es not_active Application Discontinuation
-
2008
- 2008-01-02 NO NO20080006A patent/NO20080006L/no not_active Application Discontinuation
- 2008-01-06 IL IL188614A patent/IL188614A0/en unknown
- 2008-01-14 EC EC2008008104A patent/ECSP088104A/es unknown
- 2008-01-14 ZA ZA200800408A patent/ZA200800408B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
KR20080034921A (ko) | 2008-04-22 |
ZA200800408B (en) | 2008-12-31 |
EP1904434A2 (fr) | 2008-04-02 |
MX2008000680A (es) | 2008-03-14 |
ECSP088104A (es) | 2008-04-28 |
BRPI0613031A2 (pt) | 2012-01-03 |
GT200600308A (es) | 2007-04-10 |
US20070015828A1 (en) | 2007-01-18 |
IL188614A0 (en) | 2008-04-13 |
WO2007011594A3 (fr) | 2007-04-26 |
WO2007011594A2 (fr) | 2007-01-25 |
NO20080006L (no) | 2008-02-01 |
CA2615362A1 (fr) | 2007-01-25 |
RU2007149183A (ru) | 2009-08-20 |
JP2009501229A (ja) | 2009-01-15 |
CR9661A (es) | 2008-03-07 |
PE20070247A1 (es) | 2007-04-11 |
CN101223129A (zh) | 2008-07-16 |
TW200740724A (en) | 2007-11-01 |
AR057662A1 (es) | 2007-12-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2006270380A1 (en) | Highly selective serotonin and norepinephrine dual reuptake inhibitor and use thereof | |
RU2178409C2 (ru) | 6-диметиламинометил-1-фенилциклогексановые соединения в качестве фармацевтически действующих веществ и способы их получения (варианты) | |
US6342533B1 (en) | Derivatives of (−)-venlafaxine and methods of preparing and using the same | |
US6197828B1 (en) | Derivatives of (+)-venlafaxine and methods of preparing and using the same | |
AU4062700A (en) | Derivatives of venlafaxine and methods of preparing and using the same | |
JP2013209390A (ja) | モノアミン再取り込み阻害剤としてのシクロアルキルアミン | |
BRPI0712299A2 (pt) | Formulação de liberação modificada com um núcleo de comprimido; formulação de liberação modificada em multipartículas; cápsula compreendendo as multipartículas; embalagem laminada compreendendo as multipartículas; e método de tratamento da síndrome do intestino irritável em um mamífero necessitado. | |
KR101528326B1 (ko) | (―)o―데스메틸벤라팍신을 포함하는 고체 형태들 및 그들의 용도 | |
US7595340B2 (en) | Serotonin and norepinephrine reuptake inhibitor and uses thereof | |
JP2011522893A (ja) | アルファアドレナリン介在症状の治療方法 | |
JP2010535174A (ja) | N−ピペリジン−4−イルメチルアミド誘導体及びモノアミン神経伝達物質再取り込み阻害薬としてのその使用 | |
SK9802002A3 (en) | Aminomethyl-phenyl-cyclohexanone derivatives, the method for the production thereof, medicaments comprising said substances and their use | |
AU2018221705B2 (en) | 7-membered aza-heterocyclic containing delta-opioid receptor modulating compounds, methods of using and making the same | |
US7687520B2 (en) | Serotonin and norepinephrine reuptake inhibitors and uses thereof | |
AU3106200A (en) | Derivatives of (+)-venlafaxine and methods of preparing and using the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK1 | Application lapsed section 142(2)(a) - no request for examination in relevant period |